Atlas Trials

Dai, Guanghai

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Dai, Guanghai

RecordFirmDate
Safety and Efficacy of Fruquintinib Plus Nab-Paclitaxel and Iparomlimab and Tuvonralimab Injection in the Second-Line Treatment for Immunotherapy-experienced Advanced Gastric Cancer (NCT07392346)Dai, Guanghai2025-12-01
Safety and Efficacy of Fruquintinib Plus Chidamide and Sintilimab in the Third and Later Line Treatment of MSS/pMMR Metastatic Colorectal Cancer (NCT06685276)Dai, Guanghai2024-08-16
Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer (NCT06708858)Dai, Guanghai2024-08-15
Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV (NCT06782685)Dai, Guanghai2024-06-23
Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer (NCT04027764)Dai, Guanghai2019-05-01

Track Dai, Guanghai automatically

Every clearance here is in the API, with alerts when new ones post.